20 June 2013
Keywords: samaritan, updates, ad, hiv, drug, pharmaceuticals, usa-based
Article | 18 April 2005
Samaritan Pharmaceuticals, a USA-based drug developer, has updated its Alzheimer's disease and HIV drug programs.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 April 2005
19 June 2013
© 2013 thepharmaletter.com